Skip to content

Clinical trials

Completed Lysosomal Storage Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Status: Completed Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20112
20131
20142
20151
20161
20171
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.2
BioMarin Pharmaceutical2
Shire2
ZevraDenmark2
Azafaros B.V.1
Sangamo Therapeutics1
Spark Therapeutics, Inc.1
Sumitomo Pharma Switzerland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases12
Genetic Diseases, Inborn3
Cholesterol Ester Storage Disease2
Infant, Newborn, Diseases2
Lipid Metabolism Disorders2
Lipidoses2
Metabolic Diseases2
Metabolism, Inborn Errors2
Mucopolysaccharidosis II2
Mucopolysaccharidosis IV2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.